SynthesisRevista peruana de medicina experimental y salud publica
[Type 2 diabetes mellitus in peru: a systematic review of prevalence and incidence in the general population].
Synthesis in Revista peruana de medicina experimental y salud publica. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 82 citations in OpenAlex.
- Feasibility and acceptability of e-learning training about diabetes and insulin usage to Peruvian healthcare professionals.BMJ open quality · 2026Article
- Cultural adaptation and preliminary psychometric assessment of the IMEVID questionnaire for assessing lifestyle in adults with type 2 diabetes in Peru.Journal of patient-reported outcomes · 2026Article
- Prevalence of diabetes and prediabetes in Peru: a systematic review and meta-analysis.Diabetology & metabolic syndrome · 2025Article
- Awareness, treatment, and control of diabetes in South America: A systematic review and meta-analysis.Archives of endocrinology and metabolism · 2025Article
- Glucose metabolism disorders and changes in cardiovascular risk among adult Peruvian population.Wellcome open research · 2024Article
- Improving health outcomes of people with diabetes: target setting for the WHO Global Diabetes Compact.Lancet (London, England) · 2023Article
- Type 2 Diabetes Mellitus andInternational journal of environmental research and public health · 2022Article
- Multimorbidity Patterns among People with Type 2 Diabetes Mellitus: Findings from Lima, Peru.International journal of environmental research and public health · 2022Article
- Peru - Progress in health and sciences in 200 years of independence.Lancet regional health. Americas · 2022Review
- Aggregation and combination of cardiovascular risk factors and their association with 10-year all-cause mortality: the PERU MIGRANT Study.BMC cardiovascular disorders · 2021Article
- Current State of Diabetes Mellitus Prevalence, Awareness, Treatment, and Control in Latin America: Challenges and Innovative Solutions to Improve Health Outcomes Across the Continent.Current diabetes reports · 2020Review
- The contribution of specific non-communicable diseases to the achievement of the Sustainable Development Goal 3.4 in Peru.PloS one · 2020Article
- Diabetes-Prev Scale: validation of preventive measures for type 2 diabetes in inhabitants of Cajamarca, validation design.Revista CuidarteArticle
- Article
- In vitro antioxidant capacity of Corryocactus brevistylus (sanky) and its effect on the pancreas morphology of alloxan-induced diabetic rats.Revista peruana de medicina experimental y salud publicaArticle
- Incidence rate of stroke in Peru.Revista peruana de medicina experimental y salud publicaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
Abstract
Objetives. To identify prevalence and incidence studies of type 2 diabetes mellitus in the general adult population in Peru. MATERIALS AND
methodsObservational studies involving randomly selected individuals from the general population were evaluated. The definition of diabetes had to include at least one laboratory parameter (e.g. baseline glucose). LILACS, SciELO, Scopus, Medline, Embasem and Global Health were reviewed without restriction. Risk of bias was assessed using the Newcastle-Ottawa scale.
resultsThe search identified 909 results; additionally, an article from another source was added. After evaluating the results, 20 articles representing nine studies were selected (n=16 585). One of the studies was national in scope and another semi-national (ENINBSC, 2004-05 and PERUDIAB, 2010-12). The first study reported a prevalence of 5.1% in subjects ≥35 years, while the second reported 7.0% in subjects ≥25 years. Other studies focused on populations in one or more cities in the country, or on selected population groups, such as the PERU MIGRANT study (2007-08) which reported the prevalence of diabetes in subjects in rural areas (0.8%), in rural-urban migrants (2.8%), and in urban areas (6.3%). Three studies followed up prospectively, one of them being PERUDIAB: a cumulative incidence of 19.5 new cases per 1,000 people per year. The risk of bias was low in all studies.
conclusionsPopulation studies indicate that the prevalence of diabetes has increased and that there are approximately two new cases per 100 people per year. Evidence is still scarce in the jungle and in rural populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.